Literature DB >> 21063914

Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers.

Yeunpo Chiang1, Yongxi Song, Zhenning Wang, Yue Chen, Zhenyu Yue, Huimian Xu, Chengzhong Xing, Zhuangkai Liu.   

Abstract

BACKGROUND: MicroRNAs (miRNAs) are small, non-coding RNAs of endogenous origin, they have been increasingly shown to have aberrant expression in many tumor types. miR-203 has not been comprehensively investigated in gastric and colorectal cancers.
METHODS: Total RNA was extracted from tissues of 212 patients with gastric or colorectal cancer as well as from seven gastric and colorectal cell lines. We determined the expression of miR-203 by real-time PCR and calculated using the 2-ΔΔCt method. Then, we assessed miR-203 expression and clinicopathologic characteristics. Finally, we studied the effect of miR-203 on cell proliferation in SGC-7901 cells by MTT.
RESULTS: miR-203 has significantly low expression in colorectal cancer tissues (p < 0.001, paired t test) and cancer cell lines compared to non-tumor counterparts. Moreover, low expression of miR-203 was correlated with tumor size (p = 0.015, non-parametric test) and pT stage (p = 0.005) in colorectal cancer. Although expression of miR-203 was not significant in gastric cancer tissues (p = 0.124), interestingly, miR-203 was correlated with tumor size (p = 0.023), macroscopic type (p = 0.045), and pT stage (p = 0.013). Furthermore, we found miR-203 can inhibit the cell proliferation in SGC-7901 cells.
CONCLUSION: miR-203 may be related to the proliferation and invasion of gastric and colorectal cancers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21063914     DOI: 10.1007/s11605-010-1367-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  35 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.

Authors:  Yue Chen; Yongxi Song; Zhenning Wang; Zhenyu Yue; Huimian Xu; Chengzhong Xing; Zhuangkai Liu
Journal:  J Gastrointest Surg       Date:  2010-04-27       Impact factor: 3.452

3.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

4.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

5.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

6.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

7.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

8.  Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.

Authors:  Xabier Agirre; Amaia Vilas-Zornoza; Antonio Jiménez-Velasco; José Ignacio Martin-Subero; Lucia Cordeu; Leire Gárate; Edurne San José-Eneriz; Gloria Abizanda; Paula Rodríguez-Otero; Puri Fortes; José Rifón; Eva Bandrés; María José Calasanz; Vanesa Martín; Anabel Heiniger; Antonio Torres; Reiner Siebert; José Román-Gomez; Felipe Prósper
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

9.  Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival.

Authors:  Thomas Greither; Lukasz F Grochola; Andrej Udelnow; Christine Lautenschläger; Peter Würl; Helge Taubert
Journal:  Int J Cancer       Date:  2010-01-01       Impact factor: 7.396

10.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

View more
  46 in total

1.  Epigenetic inactivation of miR-203 as a key step in neural crest epithelial-to-mesenchymal transition.

Authors:  Estefanía Sánchez-Vásquez; Marianne E Bronner; Pablo H Strobl-Mazzulla
Journal:  Development       Date:  2019-04-11       Impact factor: 6.868

2.  MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma.

Authors:  Melanie Rammer; Gerald Webersinke; Sophie Haitchi-Petnehazy; Eva Maier; Hubert Hackl; Pornpimol Charoentong; Theodora Malli; Maria Steinmair; Andreas L Petzer; Holger Rumpold
Journal:  Clin Exp Metastasis       Date:  2017-11-13       Impact factor: 5.150

3.  Expression levels of microRNA-192 and -215 in gastric carcinoma.

Authors:  Yeunpo Chiang; Xin Zhou; Zhenning Wang; Yongxi Song; Zhuangkai Liu; Fang Zhao; Jinliang Zhu; Huimian Xu
Journal:  Pathol Oncol Res       Date:  2011-12-29       Impact factor: 3.201

4.  Epigenetic Silencing of miR-203 Upregulates SNAI2 and Contributes to the Invasiveness of Malignant Breast Cancer Cells.

Authors:  Zhiqian Zhang; Baotong Zhang; Weidong Li; Liya Fu; Li Fu; Zhengmao Zhu; Jin-Tang Dong
Journal:  Genes Cancer       Date:  2011-08

5.  Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2).

Authors:  Yingyi Liu; Sujie Gao; Xuebo Chen; Meihan Liu; Cuiying Mao; Xuedong Fang
Journal:  Tumour Biol       Date:  2016-05-28

6.  MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer.

Authors:  Jinxin Shi; Ping Chen; Jingxu Sun; Yongxi Song; Bin Ma; Peng Gao; Xiaowan Chen; Zhenning Wang
Journal:  Oncol Lett       Date:  2017-03-22       Impact factor: 2.967

7.  MicroRNA analysis of microdissected normal squamous esophageal epithelium and tumor cells.

Authors:  Liang Zhu; Wusheng Yan; Jaime Rodriguez-Canales; Alex M Rosenberg; Nan Hu; Alisa M Goldstein; Philip R Taylor; Heidi S Erickson; Michael R Emmert-Buck; Michael A Tangrea
Journal:  Am J Cancer Res       Date:  2011       Impact factor: 6.166

8.  Comparative effects of diet and carcinogen on microRNA expression in the stem cell niche of the mouse colonic crypt.

Authors:  Manasvi S Shah; Eunjoo Kim; Laurie A Davidson; Jason M Knight; Roger S Zoh; Jennifer S Goldsby; Evelyn S Callaway; Beyian Zhou; Ivan Ivanov; Robert S Chapkin
Journal:  Biochim Biophys Acta       Date:  2015-10-19

Review 9.  Role of microRNAs in the immune system, inflammation and cancer.

Authors:  Jennifer Raisch; Arlette Darfeuille-Michaud; Hang Thi Thu Nguyen
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

10.  microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.

Authors:  Yeunpo Chiang; Yongxi Song; Zhenning Wang; Zhuangkai Liu; Peng Gao; Jiwang Liang; Jinliang Zhu; Chengzhong Xing; Huimian Xu
Journal:  Exp Ther Med       Date:  2011-12-28       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.